Leon, a German enabler of nano technology for the pharmaceutical industry, has secured Series B funding. No financial terms were disclosed. The investors included TVM Life Science Innovation I.L.P., CD-Venture GmbH, Albany Private Equity Holdings Pty Ltd, Eckenstein-Geigy-Stiftung, LOF Leon Partnership, L.P., Evotec SE and BayBG.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: